B
BONESUPPORT
Injectable osteoconductive biomaterials for the treatment of fragility fractures
About BONESUPPORT
BONESUPPORT is a medical technology company specializing in the development and commercialization of innovative injectable bioceramic bone graft substitutes. These substitutes are designed to promote bone healing and regeneration, providing an alternative to traditional bone grafts. The company primarily serves orthopedic surgeons, hospitals, and clinics that treat patients with bone disorders, fractures, and other skeletal conditions.
Read full description
Operating in the global healthcare market, BONESUPPORT focuses on regions including Europe, North America, and Asia. The company's flagship product, CERAMENT, is a synthetic bone graft substitute that can be combined with drugs to enhance bone healing. This product is particularly useful in treating bone infections, fractures, and defects, offering a less invasive and more effective solution compared to traditional methods.
BONESUPPORT's business model revolves around research and development (R&D), manufacturing, and sales of its bioceramic products. The company invests heavily in clinical trials and scientific research to validate the efficacy and safety of its products. Revenue is generated through the direct sale of these products to healthcare providers and through partnerships with other medical companies.
The company was founded by Professor Lars Lidgren in the early 2000s, with the vision of creating synthetic solutions to improve the quality of life for patients with bone disorders. Over the years, BONESUPPORT has expanded its product pipeline to include combination products that release drugs to further enhance bone healing. The company continues to innovate, aiming to broaden the clinical applications of its technology.
Key personnel include Kristina Ingvar, who oversees global quality and regulatory compliance, ensuring that BONESUPPORT meets stringent international standards. The company collaborates with various partners worldwide to expand its reach and impact in the medical field.
At a glance
- Founded
- 1999
- Headquarters
- Lund Municipality, Sweden
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning BONESUPPORT.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A6 investors entered at this stage
Innovations Kapital
Ferd
Teknoinvest
HealthCap
NBGI Ventures
Vencorp Partners
Series B and later7 investors entered at this stage
Industrifonden
Lundbeckfonden
Lundbeckfonden Ventures
IPF Partners
Kreos Capital
AP3
SEB
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
4 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about BONESUPPORT on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BONESUPPORT on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.